The Double-Edged Sword of Bacterial Nitric Oxide: From Fundamental Conflict to Engineered Therapeutics
محل انتشار: مجله علوم پیشرفته زیست پزشکی، دوره: 16، شماره: 3
سال انتشار: 1405
نوع سند: مقاله ژورنالی
زبان: انگلیسی
مشاهده: 79
فایل این مقاله در 12 صفحه با فرمت PDF قابل دریافت می باشد
- صدور گواهی نمایه سازی
- من نویسنده این مقاله هستم
استخراج به نرم افزارهای پژوهشی:
شناسه ملی سند علمی:
JR_JABS-16-3_002
تاریخ نمایه سازی: 17 مهر 1405
چکیده مقاله:
Nitric oxide (NO) is a multifaceted signaling molecule with important roles in both prokaryotic and eukaryotic systems. In bacteria, NO is produced endogenously through several biochemical pathways, including the enzymatic activity of bacterial NO synthases (bNOS) and the respiratory denitrification enzymes known as nitrite reductases (NirK and NirS). These systems contribute to bacterial energy metabolism, stress responses, and intercellular signaling. Depending on its concentration, source, and biological context, bacterial NO may promote biofilm formation and antibiotic tolerance, whereas host-derived NO can contribute to bacterial clearance. Major bacterial genera reported to produce NO include Bacillus subtilis, Deinococcus radiodurans, Geobacillus stearothermophilus, Lactobacillus fermentum, and Staphylococcus aureus, as well as Neisseria, Haemophilus, Veillonella, Granulicatella, and Prevotella spp. Recent advances in molecular biology and synthetic biology have greatly expanded the repertoire of available approaches for engineering bacteria to produce NO at high or controllable biological levels. For example, Escherichia coli Nissle ۱۹۱۷ and Lactobacillus species have been engineered to express inducible NOS enzymes under tightly regulated promoters. Engineered therapeutics, including selective bNOS inhibitors, nanoparticle-delivered NO donors, and NO-antibiotic synergistic regimens, may harness this duality for therapeutic benefit. To exploit concentration-dependent effects that trigger biofilm dispersal at nanomolar levels followed by bactericidal bursts, next-generation NO-based therapies will need to achieve precise spatial and temporal control. Key areas of progress include decoding how bacteria detect NO from both host and self, engineering smart biomaterials that release NO in response to the infection microenvironment, and developing bNOS inhibitors that selectively target bacterial isoforms. In addition, modulation of NO in conjunction with other gasotransmitter systems, such as H₂S and CO, together with NO-sensing probiotic therapeutics and synthetic biology approaches, may offer promising strategies for improving NO production and therapeutic application.
کلیدواژه ها:
نویسندگان
محمد قربانی
Department of Pathology, School of Allied Medical Sciences, Fasa University of Medical Sciences, Fasa, Iran
عبدالمجید قاسمیان
Noncommunicable Diseases Research Center, Fasa University of Medical Sciences, Fasa, Iran
مراجع و منابع این مقاله:
لیست زیر مراجع و منابع استفاده شده در این مقاله را نمایش می دهد. این مراجع به صورت کاملا ماشینی و بر اساس هوش مصنوعی استخراج شده اند و لذا ممکن است دارای اشکالاتی باشند که به مرور زمان دقت استخراج این محتوا افزایش می یابد. مراجعی که مقالات مربوط به آنها در سیویلیکا نمایه شده و پیدا شده اند، به خود مقاله لینک شده اند :